• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

NeutraKine®M-CSF Monoclonal antibody

NeutraKine®M-CSF Monoclonal Antibody for ELISA, Neutralization

Host / Isotype

Mouse / IgG1

Reactivity

Human

Applications

ELISA, Neutralization

Conjugate

Unconjugated

CloneNo.

4C6C5

Cat no : 69033-1-Ig

Synonyms

CSF 1, CSF1, Lanimostim, M CSF, MCSF, M-CSF, NeutraKine®M-CSF

Validation Data Gallery

Filter:
  • Neutralization experiment of NeutraKine®M-CSF using NeutraKine®M-CSF Monoclonal antibody (69033-1-Ig)

    Neutralization experiment of NeutraKine®M-CSF using 69033-1-Ig

    Recombinant human M-CSF(Cat.NO. HZ-1192) stimulates the proliferation of OCI-AML5 cells in a dose-dependent manner (blue curve, refer to bottom X-left Y). The activity of human M-CSF (5 ng/mL) is neutralized by mouse anti-human M-CSF monoclonal antibody 69033-1-Ig at serial dose (red curve, refer to top X-right Y). The ND50 is typically 0.1-0.4 μg/mL. The control mouse anti-human M-CSF monoclonal antibody 69533-1-Ig could recognize human M-CSF, but could not neutralize human M-CSF at serial does at the range of 0.976563-16000ng/mL(green curve, refer to top X-right Y).

  • Neutralization experiment of NeutraKine®M-CSF using NeutraKine®M-CSF Monoclonal antibody (69033-1-Ig)

    Neutralization experiment of NeutraKine®M-CSF using 69033-1-Ig

    Recombinant human M-CSF (Cat.NO. HZ-1192) stimulates proliferation of OCI-AML5 cells in a dose dependent manner (blue curve, refer to bottom X-left Y axis). The activity of human M-CSF (5ng/mL HZ-1192) is neutralized by mouse anti-human M-CSF monoclonal antibody 69033-1-Ig at serial dose (red curve, refer to top X-right Y axis). The ND50 is typically 0.1-0.4 μg/mL.

  • ELISA experiment of Recombinant protein using NeutraKine®M-CSF Monoclonal antibody (69033-1-Ig)

    ELISA experiment of Recombinant protein using 69033-1-Ig

    Indirect ELISA was carried out by coating recombinant Human M-CSF (Cat.NO. HZ-1192) at 70 ng/well followed by blocking and adding serial diluted M-CSF antibody 69033-1-Ig and 69533-1-Ig respectively. Signal was developed with TMB and stopped by H2SO4. Signal strength was measured by absorbance at 450 nm.

NeutralizationOCI-AML5 cells

Product Information

69033-1-Ig targets NeutraKine®M-CSF in ELISA, Neutralization applications and shows reactivity with Human samples.

Tested Reactivity Human
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Affinity
KD=8.48 x 10-9M
KOff=4.75 x 10-4M
KOn=5.60 x 104M
Immunogen human HumankineM-CSF protein HZ-1192
Full Name colony stimulating factor 1 (macrophage)
Gene Symbol M-CSF
Gene ID (NCBI) 1435
Conjugate Unconjugated
Form Lyophilized Powder
Purification MethodProtein G purification
Storage Buffer Sterile PBS.
Endotoxin<0.1 EU/μg
ReconstitutionThis product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use.
Stability and StorageLyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products.

Background Information

M-CSF plays an essential role in the regulation of survival, proliferation, and differentiation of hematopoietic precursor cells, especially mononuclear phagocytes. M-CSF promotes the release of proinflammatory chemokines and thereby plays an important role in innate immunity and in inflammatory processes. It also plays an important role in the regulation of osteoclast proliferation and differentiation, the regulation of bone resorption, and is required for normal bone development. On the cellular level, M-CSF promotes reorganization of the actin cytoskeleton, regulates the formation of membrane ruffles, cell adhesion, and cell migration, and plays a role in lipoprotein clearance.

This antibody is used to neutralize the bioactivity of M-CSF.